Facebook
Twitter
LinkedIn
ForwardNeurology in Clinical Practice Online CME Course
Course Directors: Devon Rubin, M.D. and Maisha Robinson, M.D.
This online CME course provides a comprehensive, evidence-based review in recent advances in the evaluation, diagnosis, treatment and management of neurological disorders. The course consists of case-based presentations that serve as a primer of common neurological clinical problems.
Registration Fee: $399.00
Target Audience
This course is designed for any provider who sees patients with neurologic disease including: neurologists, psychiatrists, primary care physicians including internists and family care practitioners, and allied health personnel including nurse practitioners, physician assistants and nurses.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Utilization of this Mayo Clinic online (enduring materials) course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be in this course.
- Assess diagnosis and management of common neurological disorders
- Distinguish the potential etiologies of cerebrovascular diseases, headache, dementia, movement disorders, epilepsy, multiple sclerosis, and neuromuscular diseases
- Develop an appropriate treatment plan for cerebrovascular diseases, headache, dementia, movement disorders, epilepsy, multiple sclerosis, and neuromuscular diseases
- Compare benefits and risks of different therapies of treatment of seizures
- Recognize different treatment options for patients with spine diseases
- Formulate a plan for patients with nervous system malignancies and paraneoplastic
- Recognize and treat different types of neurologic infectious diseases
- Formulate an algorithm for evaluating patients with peripheral neuropathy, neuromuscular junction disorders, and ALS
- Develop palliative care and pain management strategies in neurologic diseases
- Recognize the difference between primary and secondary headache syndromes
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Additional Information
| Attachment | Size |
|---|---|
 Additional Information | 235.4 KB |
Neurology in Clinical Practice Online | ||
|
|
|
| CEREBROVASCULAR DISEASE | |
| What’s New in Acute Stroke Management | Josephine F. Huang, M.D. |
| Secondary Stroke Prevention | Eugene L. Scharf, M.D. |
|
|
|
| MOVEMENT DISORDERS |
|
| Update in Parkinson’s Disease Diagnosis and Management | Ashley Pena, M.D. |
| Dystonia, Tremors, and Other Movement Disorders | Shyamal Mehta, M.D., Ph.D. |
|
|
|
| NEURO=OPHTHALMOLOGY |
|
| Neuroophthalmology Update | Eric Eggenberger, M.D., Ph.D. |
|
|
|
| NEUROMUSCULAR DISEASES | |
| Peripheral Neuropathy: Diagnosis and Treatment | Devon Rubin, M.D. |
| Neuromuscular Junction Disorders: Diagnostic and Treatment Advances | Julie Khoury, M.D. |
| What’s New in Motor Neuron Diseases | Eric Sorenson, M.D. |
|
|
|
| HEADACHE | |
| Headache: Evaluation and When to Worry | Joseph Sirven, M.D. |
| Acute and Prophylactic Management of Primary Headache | Fred Michael Cutrer, M.D. |
| Atypical Headache Syndromes | Todd Rozen, M.D. |
|
|
|
| EPILEPSY | |
| Treatment Strategies in Epilepsy: How to Choose the Right Medication | Anteneh Feyissa M.D. |
| Treatment of Epilepsy in Special Populations | Katherine H. Noe, M.D., Ph.D. |
|
|
|
| SESSION TOPIC: DEMENTIA |
|
| Update in Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease | Ronald Petersen, M.D., Ph.D. |
| Treatment of Alzheimer’s Disease | Neill Graff-Radford, M.D. |
| Non-Alzheimer’s Dementias | Bryan Woodruff, M.D. |
|
|
|
| DEMYELINATING AND AUTOIMMUNE DISEASES | |
| Multiple Sclerosis: Advances in Diagnosis | B. Mark Keegan, M.D. |
| Multiple Sclerosis: Treatment Update | Dean Wingerchuk, M.D. |
| Myelopathies: Approach to Diagnosis | Neeraj Kumar, M.D. |
| Autoimmune and Paraneoplastic Disorders | Alfonso (Sebastian) Lopez Chiriboga, M.D. |
|
|
|
| NECK AND BACK PAIN | |
| Update in Treatment Options for Neck and Back Pain | H. Gordon Deen, M.D. |
|
|
|
| NEURO-INFECTIOUS DISEASES |
|
| Update in CNS Infections | Allen Aksamit, M.D. |
|
|
|
| AUTONOMIC DISORDERS | |
| Evaluation and Management of Autonomic Disorders | William Cheshire, M.D. |
|
|
|
| PAIN |
|
| Neuropathic Pain Management | James Watson, M.D. |
|
|
|
| SLEEP DISORDERS |
|
| Evaluation and Management of Sleep Disorders | Brynn Dredla, M.D. |
|
|
|
| GAIT DISORDERS | |
| Assessment of Gait Disorders | Farwa Ali, M.D. |
|
|
|
| EMERGENCY NEUROLOGY |
|
| Current Issues in Emergency Neurology | Jason Siegel, M.D. |
|
|
|
| CONCUSSION |
|
| Concussion and Traumatic Brain Injury | Juliana VanderPluym, M.D. |
|
|
|
| NEURO-ONCOLOGY |
|
| Neuro-Oncology Update | Julie Hammack, M.D. |
|
|
|
| PALLATIVE CARE IN NEUROLOGY |
|
| Palliative Care in Neurology | Masha Robinson, M.D. |
|
|
|
| DEMENTIA |
|
| Update in Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease | Ronald Petersen, M.D., Ph.D. |
| Treatment of Alzheimer’s Disease | Neill Graff-Radford, M.D. |
| Non-Alzheimer’s Dementia | Bryan Woodruff, M.D. |
|
|
|
Course Directors:
 Devon Rubin, M.D. |  Maisha Robinson, M.D. |
Faculty:
Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
Listed below are individuals with control of the content of this program who have disclosed…
Relevant financial relationship(s) with industry:
Fred Michael Cutrer, M.D. | Consultant | Biohaven Pharmaceuticals |
Neill Graff-Radford, M.D.
| Grant/Research Support | Engaged in multicenter studies funded by Lilly, Biogen, Abbvie and Esai |
Shyamal Mehta, M.D., Ph.D.
| Consultant | Adamas Pharmaceuticals, Kyowa Kirin, Abbott, Lundbeck, Neurocrine, CNS Ratings |
Ronald Petersen, M.D., Ph.D.
| Consultant | Roche, Inc.; Merck, Inc.; Biogen, Inc.; Eisai, Inc.; Genentech, Inc. (Data Monitoring Committee) |
Joseph Sirven, M.D.
| Grant/Research
Consultant
Other | UCB
American Academy of Neurology, Editor- in chief Brain & Life en Espanol
Federal Aviation Administration |
Eric Sorenson, M.D. | Grant/Research | Biogen and Cytokinetics in the form of Clinical trial research support |
Juliana VanderPluym, M.D.
| Consultant
Grant | Teva, Healint
Amgen, Electocore |
Dean Wingerchuk, M.D.
| Consultant
Grant/Research | MedImmune, Novartis, Biogen, Celgene, Genentech, TG Therapeutics, Arcus Medica, Third Rock Ventures, Reistone
Alexion and TerumoBCT |
No relevant financial relationship(s) with industry:
Allen Aksamit, M.D. Farwa Ali, M.D. William Cheshire, M.D. H. Gordon Deen, M.D. Brynn Dredla, M.D. Eric Eggenberger, M.D., Ph.D. Anteneh Feyissa, M.D. Julie Hammack, M.D. Josephine F. Huang, M.D. Julie Khoury, M.D.
| Neeraj Kumar, M.D. Alfonso (Sebastian) Lopez Chiriboga, M.D. Katherine H. Noe, M.D., Ph.D. Ashley Pena, M.D. Maisha Robinson, M.D. Todd Rozen, M.D. Devon Rubin, M.D. Eugene L. Scharf, M.D. Jason Siegel, M.D. James Watson, M.D. Bryan Woodruff, M.D. |
References to off-label and/or investigational usage(s) of pharmaceuticals or instruments in their presentation:
H. Gordon Deen, M.D.
| Medtronic | Infuse/bone morphogenetic protein |
Ashley Pena, M.D.
| Quetiapine
| Generic medication for off label use
|
Eugene L. Scharf, M.D. | AstraZeneca | Ticagrelor
|
Juliana VanderPluym, M.D.
| There are no FDA approved treatments for concussion. | Discussion of off-label use will be indicated as such. |
James Watson, M.D.
| Multiple pharmacologic treatments will be discussed | Off label treatment of neuropathic pain with disclosure |
Bryan Woodruff, M.D.
| Multiple Multiple | Cholinesterase inhibitors Memantine |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) please visit: https://ce.mayo.edu/content/disclosures.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 19.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 19.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
AOA
This program has been accredited by the American Osteopathic Association for 19.00 AOA Category 2-A CME credits.
Other Healthcare Professionals
A record of attendance will be available to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 19.00 AMA PRA Category 1 Credit™
- 19.00 ANCC
- 19.00 AOA Category 2-A
- 19.00 Attendance
VIRTUAL EXHIBIT HALL
Welcome to the Virtual Exhibit Hall. Analogous to booths at scientific conferences, this is a space where companies share information about their products and services, showcase their latest innovations, and connect with attendees, faculty and course directors. Check out the "booths" below to learn about each exhibitor and get connected!
If you are interested in becoming an exhibitor, please email Denise Klarich.
| Exhibitors - Click on Exhibitor Logo to Access the Virtual Booth | ||
|---|---|---|
 |  |
|
 |  |  |
 |  |  |
 |  |  |
The Virtual Exhibit Hall is paid advertising. The use of the Site and the Content, including Third Party Content, is at your own risk.
Price
Access to online streaming course is available from the date of purchase until the course expires on July 20, 2023. Credit must be claimed within that time period.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.